ACRO Financial Statements From 2010 to 2024
| ACBM Stock | USD 0 0.00 0.00% |
Check ACRO Biomedical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ACRO Biomedical's main balance sheet or income statement drivers, such as , as well as many indicators such as . ACRO financial statements analysis is a perfect complement when working with ACRO Biomedical Valuation or Volatility modules.
ACRO |
ACRO Biomedical Co Company Shares Outstanding Analysis
ACRO Biomedical's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current ACRO Biomedical Shares Outstanding | 60.04 M |
Most of ACRO Biomedical's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ACRO Biomedical Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, ACRO Biomedical Co has 60.04 M of shares currently outstending. This is 66.74% lower than that of the Healthcare sector and 43.81% lower than that of the Biotechnology industry. The shares outstanding for all United States stocks is 89.5% higher than that of the company.
ACRO Biomedical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining ACRO Biomedical's current stock value. Our valuation model uses many indicators to compare ACRO Biomedical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ACRO Biomedical competition to find correlations between indicators driving ACRO Biomedical's intrinsic value. More Info.ACRO Biomedical Co is rated second in return on equity category among its peers. It also is rated second in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ACRO Biomedical's earnings, one of the primary drivers of an investment's value.About ACRO Biomedical Financial Statements
ACRO Biomedical investors utilize fundamental indicators, such as revenue or net income, to predict how ACRO Pink Sheet might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Acro Biomedical Co., Ltd. engages in developing and marketing of nutritional products. Acro Biomedical Co., Ltd. was incorporated in 2014 and is based in Fishers, Indiana. Acro Biomedical operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in ACRO Pink Sheet
ACRO Biomedical financial ratios help investors to determine whether ACRO Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ACRO with respect to the benefits of owning ACRO Biomedical security.